Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

NCT05489458 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal

Interventions

PROCEDURE: Resection
PROCEDURE: No Resection

Sponsor

BUSQUETS, JULI